Patents by Inventor Wenjuan DONG

Wenjuan DONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220249564
    Abstract: Provided herein are methods of treating cancer in a subject including detecting an amount of PD-L1(+) natural killer (NK) cells in a biological sample from the subject and treating the subject with an anti cancer therapy. Provided herein are methods of treating cancer in a patient including isolating natural killer (NK) cells from a subject, producing a population of PD-L1(+) NK cell from the isolated NK cells, and administering the population of PD-L1(+) NK cells into the patient.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 11, 2022
    Applicant: City of Hope
    Inventors: Jianhua Yu, Michael A. Caligiuri, Wenjuan Dong
  • Publication number: 20210266461
    Abstract: In a described embodiment, a UAV and method for controlling a UAV are disclosed. The UAV is controlled along a predetermined flight path and the camera of UAV is controlled such that adjacent pictures of the captured pictures have an overlap in a predetermined range. In another embodiment, a device and method for detecting defects in image data of a UAV camera are disclosed. An image data management system for managing image data of a UAV and a client software application for performing surface scans with a UAV are also disclosed.
    Type: Application
    Filed: July 2, 2019
    Publication date: August 26, 2021
    Inventors: Tao Wei Shaun Koo, Wenjuan Dong, See Wei Yong, Cheng Lock Donny Soh, Jaime Rubio
  • Publication number: 20170266273
    Abstract: Provided are a recombinant adeno-associated virus (AAV) vector carrying human papillomavirus type 16 (HPV-16) mutation E7 antigen gene and a construction method therefor. The construction method comprises mutating the carcinogenic HPV-16 E7 antigen gene to noncarcinogenic E7 antigen gene, and then inserting the mutated gene into an AAV vector of which the structural gene has been removed, thereby obtaining the recombinant AAV vector. The recombinant AAV vector or related product can be used for preparing medications against HPV-16 infection and other diseases such as tumors caused by HPV-16 infection.
    Type: Application
    Filed: August 12, 2015
    Publication date: September 21, 2017
    Inventors: Yong LIU, Qiaolin CHEN, Zhaopeng ZENG, Wenjuan DONG, Hongji GAO, Yanhao GONG, Sha MENG, Yanwei XU, Hui ZHANG, Jing LU